Healthcare Resource Utilization and Costs Among Patients With Schizophrenia Switching From Oral Risperidone/Paliperidone to Once-Monthly Paliperidone Palmitate: A Veterans Health Administration Claims Analysis

Medicine & Life Sciences

• Antipsychotic Agents 8%
• Costs and Cost Analysis 41%
• Databases 5%
• Delivery of Health Care 40%
• Economics 7%
• Health 4%
• Health Care Costs 17%
• Health Resources 42%
• Injections 5%
• Inpatients 30%
• Insurance Claim Review 95%
• Length of Stay 14%
• Mental Health 7%
• Outpatients 14%
• Paliperidone Palmitate 100%
• Patient Acceptance of Health Care 45%
• Pharmacy 19%
• Risperidone 80%
• Schizophrenia 54%
• Therapeutics 6%
• United States Department of Veterans Affairs 81%
• Veterans Health 86%